Skip to main content
. 2012 May 31;14(3):PCC.11m01251. doi: 10.4088/PCC.11m01251

Table 2.

Slope Analyses on Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Week 2 for Patients Showing a Response at Endpoint (≥ 50% reduction in MADRS total score)

Slope Estimate (95% CI)
Adjunctive Placebo Adjunctive Aripiprazole Difference of Slope Estimates
Moderate responders (≥ 50% and < 75%) n = 79 n = 125 −0.7 (–1.5 to 0.1)
−4.1 (–4.7 to –3.5) −4.8 (–5.3 to –4.3)
Robust responders (≥ 75%) n = 39 n = 77 −1.5 (–3.0 to 0.1)
−5.6 (–6.9 to –4.4) −7.1 (–8.0 to –6.2)
All responders (≥ 50%)a n = 118 n = 202 −1.0 (–1.8 to –0.3)
−4.6 (–5.2 to –4.0) −5.7 (–6.1 to –5.2)
a

Includes patients exhibiting a ≥ 50% reduction in MADRS total score at week 6.